Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
Imprimis Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Imprimis Pharmaceuticals reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Imprimis Pharmaceuticals received on average a compensation package of $872K, a 80% decrease compared to previous year.
Average pay of disclosed executives at Imprimis Pharmaceuticals
Mark L. Baum, Chief Executive Officer, received $1.2M in total, which decreased by 84% compared to 2021. 51% of Baum's compensation, or $609K, was in salary. Baum also received $500K in non-equity incentive plan and $86K in other compensation.
Andrew R. Boll, Chief Financial Officer, received a compensation package of $764K, which decreased by 77% compared to previous year. 54% of the compensation package, or $416K, was in salary.
John P. Saharek, Chief Commercial Officer and President, ImprimisRx, earned $657K in 2022, a 75% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.